medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2021, Number 2

<< Back Next >>

Acta Ortop Mex 2021; 35 (2)

Total femur prosthesis in non-oncological patients

Luengo-Alonso G, Moreno-Beamud J, Delgado-Díaz E

Language: Spanish
References: 24
Page: 188-192
PDF size: 153.65 Kb.


ABSTRACT

Introduction: Total femoral replacement (TFR), it is an uncommon surgery in non-oncological patients. Our main objective is to review our total femur replacement surgeries and analyze functional and clinical outcomes. Material and methods: We retrospectively review our series of seven non-oncological patients treated at our center with a TFR from 2011 to 2014. After excluding patients (Oncological patients or non-follow up) we revised four patients. Paprosky bone loos classification and different values were studied: number and time of surgeries, complications, revision surgeries, functional scales, and follow-up. Results: Mean age of 78.5 years. According to Paprosky classification of femur bone loss: 1 IIIA, 2 were IIIB, 1 IV. On the other side acetabular loss: 2 I, 1 IIA, 1 IIB. Surgical time for TFR was 110 minutes on average. Three patients were need revision surgery due to instability. And every single patient suffered from chronic infection. Mean range of motion was 85 flexion, 0o extension. Comparing preoperative and postoperative Harris Hip Score for hip function was 54.9 points and Enneking score was an average of 14.25 points better in our patients with TFR. Visual analogue pain score was on average less than two points. Mean follow-up is almost seven and a half years. Conclusions: TFP has not a standardized surgical protocol yet. Infection is always present in our series and acetabular constrained components in TFR avoid instability complications. TFP should be implanted only in selected patients.


REFERENCES

  1. Friesecke C, Plutat J, Block A. Revision arthroplasty with use of a total femur prosthesis. J Bone Joint Surg Am. 2005; 87(12): 2693-701. doi: 10.2106/JBJS.D.02770.

  2. Ahmed AR. Total femur replacement. Arch Orthop Trauma Surg. 2010; 130(2): 171-6. doi: 10.1007/s00402-009-0945-2.

  3. Mankin HJ, Hornicek FJ, Harris M. Total femur replacement procedures in tumor treatment. Clin Orthop Relat Res. 2005; 438: 60-4. doi: 10.1097/00003086-200509000-00012.

  4. Morris HG, Capanna R, Campanacci D, Del Ben M, Gasbarrini A. Modular endoprosthetic replacement after total resection of the femur for malignant tumour. Int Orthop. 1994; 18(2): 90-5. doi: 10.1007/bf02484417.

  5. Steinbrink K, Engelbrecht E, Fenelon GC. The total femoral prosthesis. A preliminary report. J Bone Joint Surg Br. 1982; 64(3): 305-12.

  6. Ward WG, Dorey F, Eckardt JJ. Total femoral endoprosthetic reconstruction. Clin Orthop Relat Res. 1995; (316): 195-206.

  7. Sewell MD, Spiegelberg BGI, Hanna SA, Aston WJS, Bartlett W, Blunn GW, et al. Total femoral endoprosthetic replacement following excision of bone tumours. J Bone Joint Surg Br. 2009; 91(11): 1513-20. doi: 10.1302/0301-620X.91B11.21996.

  8. Sevelda F, Schuh R, Hofstaetter JG, Schinhan M, Windhager R, Funovics PT. Total femur replacement after tumor resection: limb salvage usually achieved but complications and failures are common. Clin Orthop Relat Res. 2015; 473(6): 2079-87. doi: 10.1007/s11999-015-4282-1.

  9. Ruggieri P, Bosco G, Pala E, Errani C, Mercuri M. Local recurrence, survival and function after total femur resection and megaprosthetic reconstruction for bone sarcomas. Clin Orthop Relat Res. 2010; 468(11): 2860-6. doi: 10.1007/s11999-010-1476-4.

  10. Berend KR, Lombardi AV, Mallory TH, Adams JB, Dodds KL. Total femoral arthroplasty for salvage of end-stage prosthetic disease. Clin Orthop Relat Res. 2004; (427): 162-70. doi: 10.1097/01.blo.0000142351.88039.e8.

  11. Buchman J. Total femur and knee joint replacement with a vitallium endoprosthesis. Bull Hosp Joint Dis. 1965; 26: 21-34.

  12. Sherman SL, Cunneen KP, Walcott-Sapp S, Brause B, Westrich GH. Custom total femur spacer and second-stage total femur arthroplasty as a novel approach to infection and periprosthetic fracture. J Arthroplasty. 2008; 23(5): 781-6. doi: 10.1016/j.arth.2007.05.027.

  13. Hu QT, Jiang QW, Su GL, Shen JZ, Shen X. Total femur and adjacent joint replacement with endoprosthesis: report of 2 cases. Chin Med J (Engl). 1980; 93(2): 86-9.

  14. Porsch M, Galm R, Hovy L, Starker M, Kerschbaumer F. Total femur replacement following multiple periprosthetic fractures between ipsilateral hip and knee replacement in chronic rheumatoid arthritis. Case report of 2 patients. Z Orthop Ihre Grenzgeb. 1996; 134(1): 16-20. doi: 10.1055/s-2008-1037412.

  15. Fabroni RH, Castagno A, Aguilera AL, Steverlynck AM, Zeballos J. Long-term results of limb salvage with the Fabroni custom made endoprosthesis. Clin Orthop Relat Res. 1999; (358): 41-52.

  16. Toepfer A, Harrasser N, Petzschner I, Pohlig F, Lenze U, Gerdesmeyer L, et al. Is total femoral replacement for non-oncologic and oncologic indications a safe procedure in limb preservation surgery? A single center experience of 22 cases. Eur J Med Res. 2018; 23(1): 5. doi: 10.1186/s40001-018-0302-4.

  17. Amanatullah DF, Trousdale RT, Hanssen AD, Lewallen DG, Taunton MJ. Non-oncologic total femoral arthroplasty: retrospective review. J Arthroplasty. 2014; 29(10): 2013-5. doi: 10.1016/j.arth.2014.05.012.

  18. Ramanathan D, Siqueira MB, Klika AK, Higuera CA, Barsoum WK, Joyce MJ. Current concepts in total femoral replacement. World J Orthop. 2015; 6(11): 919-26. doi: 10.5312/wjo.v6.i11.919.

  19. Paprosky WG, Bradford MS, Younger TI. Classification of bone defects in failed prostheses. Chir Organi Mov. 1994; 79(4): 285-91.

  20. Paprosky WG, Perona PG, Lawrence JM. Acetabular defect classification and surgical reconstruction in revision arthroplasty. A 6-year follow-up evaluation. J Arthroplasty. 1994; 9(1): 33-44.

  21. Luengo G, Lora-Tamayo J, Paredes D, Muñoz-Gallego I, Díaz A, Delgado E. Daptomycin plus fosfomycin as salvage therapy in a difficult-to-treat total femoral replacement infection. J Bone Joint Infect. 2018; 3(4): 207-11. doi: 10.7150/jbji.27811.

  22. Glehr M, Leithner A, Friesenbichler J, Goessler W, Avian A, Andreou D, et al. Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels. Bone Joint J. 2013; 95-B(7): 988-92. doi: 10.1302/0301-620X.95B7.31124.

  23. Marcove RC, Lewis MM, Rosen G, Huvos AG. Total femur and total knee replacement. A preliminary report. Clin Orthop Relat Res. 1977; (126): 147-52.

  24. Wu F, Fang X, Lang Z, Liu H, Duan H. Advances in total femur replacement. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2018; 32(10): 1346-50. doi: 10.7507/1002-1892.201804006.



EVIDENCE LEVEL

IV




2020     |     www.medigraphic.com